Linear localized morphea associated with golimumab in a patient with spondyloarthritis

Reumatol Clin (Engl Ed). 2020 Jul-Aug;16(4):303-305. doi: 10.1016/j.reuma.2018.06.003. Epub 2018 Aug 14.

[Article in English, Spanish]

Authors

Vicenç Torrente-Segarra¹, Pedro Campo², Sergi Heredia³, Cristina Heras-Mulero², Maria Bonet³

Affiliations

¹ Servicio de Reumatología, Hospital Comarcal Alt Penedès, Vilafranca del Penedès, Barcelona, España. Electronic address: vtorrente@csap.cat.
² Servicio de Dermatología, Hospital Comarcal Alt Penedès, Vilafranca del Penedès, Barcelona, España.
³ Servicio de Reumatología, Hospital Comarcal Alt Penedès, Vilafranca del Penedès, Barcelona, España.

PMID: 30120020
DOI: 10.1016/j.reuma.2018.06.003

No abstract available

Publication types

Case Reports
Review

MeSH terms

Anti-Inflammatory Agents / adverse effects*
Anti-Inflammatory Agents / therapeutic use
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Drug Eruptions / etiology*
Female
Humans
Middle Aged
Scleroderma, Localized / chemically induced*
Spondylarthritis / drug therapy*

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal
golimumab